71 search results for lung cancer
Annual Conference
the Following Topics: Biliary Tract Cancers Bladder Cancer Colorectal Cancer Hepatocellular Cancer Head and Neck Cancers Non-Metastatic Non-Small Cell Lung Cancer Multiple Myeloma Oligometastatic Prostate Plural and Peritoneal Mesothelioma Small Cell Lung Cancer Thyroid Cancer Exhibit Hall Visit, for cancer and best practices for cancer care delivery. There is also plenty of time to network, from leading cancer centers will come together to discuss updates to NCCN Guidelines®, the latest
https://www.nccn.org/education-research/educational-events-and-programs/annual-conferencePAS Policy Report Precision Medicine Final
for the appropriate biomarker tests. Lung and other cancers require significant surgical intervention, and Implications for Quality, Accessible, and Equitable Cancer Care In recent years, targeted medicines have offered dramatic advancements in cancer care outcomes across a wide variety of cancer types. However, as cancer care becomes increasingly personalized, access to biomarker testing and targeted, , the National Comprehensive Cancer Network (NCCN ® ) conducted a patient advocacy scan
https://www.nccn.org/docs/default-source/oncology-policy-program/pas-policy-report-precision-medicine-final.pdf?sfvrsn=468e4a2b_1Guidelines for Patients
Lung Cancer Screening Version: 2023, Lung Cancer - Early and Locally Advanced Version: 2024 Non-Small Cell Lung Cancer - Metastatic Version: 2024, Lung Cancer Version: 2024 Soft Tissue, Cancer Version: 2023 Adrenal Tumors
https://www.nccn.org/guidelines/patientsSubmission Request Form
- 2.2024 Basal Cell Skin Cancer - 3.2024 B-Cell Lymphomas - 3.2024 Biliary Tract Cancers - 4.2024, - 1.2024 Central Nervous System Cancers - 3.2024 Cervical Cancer - 4.2024 Chronic Lymphocytic, - 2.2024 Esophageal and Esophagogastric Junction Cancers - 4.2024 Gastric Cancer - 4.2024, Hodgkin Lymphoma - 4.2024 Kaposi Sarcoma - 1.2025 Kidney Cancer - 2.2025 Lung Cancer Screening, Rectal Cancer - 4.2024 Small Bowel Adenocarcinoma - 5.2024 Small Cell Lung Cancer - 3.2025 Smoking
https://www.nccn.org/guidelines/submissions-request-to-the-guidelines-panels/submission-request-formTreatment by Cancer Type
Treatment by Cancer Type, Version: 2.2024 Non-Small Cell Lung Cancer, Small Cell Lung Cancer Version: 3.2025, . NCCN Guidelines Treatment by Cancer Type, Version: 1.2024 Basal Cell Skin Cancer, Version: 3.2024 Biliary Tract Cancers
https://www.nccn.org/guidelines/category_1Annual Report 2023
for Non-Small Cell Lung Cancer 808,760 Downloads NCCN Guidelines for Prostate Cancer 651,712 Downloads, cancers, including cervical cancer, ovarian/fallopian tube/primary peritoneal cancers and uterine, to create a pilot version of NCCN Harmonized Guidelines™ for Vietnam: Non-Small Cell Lung Cancer, , and prostate cancers; management of adult cancer pain; and ovarian/fallopian tube/primary peritoneal cancers, of cancers • Outlines a rational approach for building cancer management systems based
https://www.nccn.org/docs/default-source/about/annual-report-2023.pdf?sfvrsn=8411082_31World Cancer Day - Every February 4
World Cancer Day - Every February 4, Screening for HIM Act H.R.4286 - Increasing Access to Lung Cancer Screening Act H.R.4363/S. 2213, . World Cancer Day – Every February 4 World Cancer Day is a global awareness day organized by the Union of International Cancer Control (UICC) every February 4th, disparities in cancer treatment and outcomes. The National Comprehensive Cancer Network® (NCCN®), American Cancer Society Cancer Action Network (ACS CAN), and the National Minority Quality Forum
https://www.nccn.org/home/world-cancer-dayMiddle East & North Africa
2.2022 (English) Non-Small Cell Lung Cancer Version 3.2022 (English) Ovarian Cancer/Fallopian Tube Cancer, of cancer-related information including modification of NCCN Guidelines to colleagues in the MENA, for the MENA region focused on Ovarian Cancer; Genetic/Familial High-Risk Assessment for Breast, Comprehensive Cancer Network (MENA-NCCN) MENA Regional Center for NCCN Collaboration for more information. NCCN Guidelines Adaptations Middle East & North Africa (MENA) Editions Adult Cancer Pain
https://www.nccn.org/global/global-program/middle-east-north-africaThe Impact of Policy Regulation on Guideline-Concordant Care Globally Summary Article
specific cancers. One significant step to reduce cancer incidence is to eliminate tobacco usage, based on the WHO EML for cancers with the highest incidence in LLMICs. These cancers include lung, of patients with cancer lack access to essential medicines, crucial health infrastructure, and coordinated multidisciplinary cancer care. One path forward is an active effort from policymakers, cancer types and standardization of care through clinical practice guidelines in oncology. Moreover
https://www.nccn.org/docs/default-source/global/the-impact-of-policy-regulation-on-guideline-concordant-care-globally-summary-article.pdf?sfvrsn=b36df21a_3Advocacy December Toolkit_2021
Cholangiocarcinoma Foundation 4 Fight Colorectal Cancer 6 GO2 Foundation for Lung Cancer 7 ICAN, NCCN Digital Booklet of Patient Advocacy Resources National Comprehensive Cancer Network, , A c c e s s i b l e , a n d Equitable Cancer Care The NCCN Digital Resource Booklet includes, to precision medicine and address related needs for people with cancer. This Booklet was developed in conjunction with The National Comprehensive Cancer Network’s ® (NCCN ® ) Virtual Patient
https://www.nccn.org/docs/default-source/oncology-policy-program/advocacy-december-toolkit_2021.pdf?sfvrsn=4c2c60da_1Chemotherapy Order Templates Reviewer Acknowledgement
- James Cancer Hospital and Solove Research Institute Central Nervous System Cancers, Diego Moores Cancer Center Head and Neck Cancers Emily Armgardt, Center Non-Small Cell Lung Cancer Sally Barbour, PharmD, BCOP, Cancer Center at the University of Pennsylvania Small Cell Lung Cancer, Shira Dinner, MD Robert H. Lurie Comprehensive Cancer Center
https://www.nccn.org/compendia-templates/nccn-templates-main/nccn-chemotherapy-order-reviewer-engagementNCCN_Oncology_Research_Program_Brochure
of patients with suspected or newly diagnosed lung cancer in Antelope Valley, one of the most underserved regions of Southern California. Antelope Valley has the highest rate of lung cancer mortality, of the first lung cancer screening program in Antelope Valley. This initiative has touched many, and treatment of lung cancer in this underserved area.” Dan J. Raz, MD City of Hope National Medical Center, that improve the lives of patients with cancer. National Comprehensive Cancer Network® Namrata Vijayvergia
https://www.nccn.org/docs/default-source/oncology-research-program-(orp)/nccn_oncology_research_program_brochure.pdf?sfvrsn=ebab0181_3About the NCCN Guidelines for Patients
than 25 years, the National Comprehensive Cancer Network® (NCCN®) has developed resources to improve the quality of cancer care. These resources include the award-winning NCCN, language to help people discuss options with their cancer care team. This library of free, for their ability to empower people with cancer and caregivers. Recent Awards, Communicator Award of Distinction for the NCCN Guidelines for Patients: Kidney Cancer
https://www.nccn.org/patientresources/patient-resources/about-the-nccn-patient-guidelinesDetection, Prevention, and Risk Reduction
Lung Cancer Screening Version: 1.2025 Prostate Cancer Early Detection Version: 2.2024, ®) are posted with the latest update date and version number. Breast Cancer, Cancer Screening and Diagnosis Version: 2.2024 Colorectal Cancer Screening Version: 1.2024
https://www.nccn.org/guidelines/category_2Latin America
(LACOG) to develop Latin America Editions of the NCCN Guidelines for Breast, Colon, Non-Small Cell Lung, Prostate Cancer, Multiple Myeloma, and Rectal Cancers. LACOG is a non-profit organization founded, dedicated to clinical and translational research in cancer. In 2021, NCCN embarked on a comprehensive new project to impact access to evidence-based care for prostate cancer in the LATAM region, and the United States focused on key updates in the NCCN Guidelines for Prostate Cancer to optimize clinical
https://www.nccn.org/global/global-program/latin-americaNCCN SOSF 2024 Thirteenth Annual Summary
, NCCN Panelists included: • Arun Krishna, PhD, Vice-President, US Franchise Head & Lung Cancer, featured on the panel. Dr. Krishna discussed the importance of lung cancer screening because the U.S., of 2023 entitled Cancer Across Geography which resulted in a subsequent JNCCN publication. Many of our, the Reducing Hereditary Cancer Act, among a variety of other federal pieces of legislation. NCCN, Guidelines® into law when appropriate, fertility preservation, access to hereditary cancer screening
https://www.nccn.org/docs/default-source/oncology-policy-program/nccn-sosf-2024-thirteenth-annual-summary.pdf?sfvrsn=5346b0f5_1NCCN_ExhibitHall_Floorplan_2024
Crossroads4Hope ............................... A9 Global Colon Cancer Association ...... A1 GO2 for Lung Cancer ........................ A16 Head and Neck Cancer Alliance......... A4 Imerman Angels, ....................................... 724 Moffitt Cancer Center ....................... 623 Roswell Park Comprehensive Cancer Center ................................... 625 REIMBURSEMENT RESOURCE ROOM Astellas, of Cancer Care Centers (ACCC) ................................. A14 Bladder Cancer Advocacy
https://www.nccn.org/docs/default-source/education-research/nccn_exhibithall_floorplan_2024.pdf?sfvrsn=66d8d76f_4AC2024 Exhibit Guide
, and thoracic cancers, which includes lung cancer. Driven by science, we are committed, Association ............ A1 GO2 for Lung Cancer .............................. A16 Head and Neck, transformative therapies in some of the world’s most common cancers, including breast cancer, e s t h a t w e s e e k t o s e r ve. Eisai is proud to support the National Comprehensive Cancer, the growth of cancers such as multiple myeloma. Everything we do gets us closer to a future where
https://www.nccn.org/docs/default-source/education-research/ac2024-exhbit-guide.pdf?sfvrsn=a658efb9_11Request for Information for Healthcare Access in the Public Health Emergency
cancers. 20 The root causes of racial disparities in access to guideline adherent cancer care, DA, de Koning HJ. Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer, leading academic cancer centers in the United States that treat hundreds of thousands of patients with cancer annually. The organization is the developer of authoritative information regarding cancer, that currently apply to 97 percent of cancers affecting patients in the United States. Access
https://www.nccn.org/docs/default-source/oncology-policy-program/access/rfi-draft-for-healthcare-access-in-the-phe.pdf?sfvrsn=a7d205a9_3Request for Information for Healthcare Access in the Public Health Emergency (PHE)
cancers. 20 The root causes of racial disparities in access to guideline adherent cancer care, DA, de Koning HJ. Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer, leading academic cancer centers in the United States that treat hundreds of thousands of patients with cancer annually. The organization is the developer of authoritative information regarding cancer, that currently apply to 97 percent of cancers affecting patients in the United States. Access
https://www.nccn.org/docs/default-source/oncology-policy-program/quality/rfi-draft-for-healthcare-access-in-the-phe.pdf?sfvrsn=5504caab_3